Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Sars-Cov-2 (Covid-19): New Discoveries and Current Challenges Publisher



Soufi GJ1 ; Hekmatnia A1 ; Nasrollahzadeh M2 ; Shafiei N2 ; Sajjadi M2 ; Iravani P3 ; Fallah S4 ; Iravani S5 ; Varma RS6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Radiology Department, School of Medicine, Isfahan University of Medical Sciences, Isfahan, 81746-73461, Iran
  2. 2. Department of Chemistry, University of Qom, Faculty of Science, Qom, 37185-359, Iran
  3. 3. Pediatrics Department, School of Medicine, Isfahan University of Medical Sciences, Isfahan, 81746-73461, Iran
  4. 4. Physical Medicine and Rehabilitation Department, School of Medicine, Isfahan University of Medical Sciences, Isfahan, 81746-73461, Iran
  5. 5. Isfahan University of Medical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, Isfahan, 81746-73461, Iran
  6. 6. Regional Centre of Advanced Technologies and Materials, Palacky University in Olomouc, Slechtitelu 27, Olomouc, 783 71, Czech Republic

Source: Applied Sciences (Switzerland) Published:2020


Abstract

SARS-CoV-2 (COVID-19) has today multiplied globally and various governments are attempting to stop the outbreak of the disease escalation into a worldwide health crisis. At this juncture, readiness, candor, clarity, and partaking of data are of paramount importance to speed up factual evaluation and starting pattern control activities, including serendipitous findings. Owing to the involvement of COVID-19, many facts regarding virulence, pathogenesis, and the real viral infection source and/or transmission mode still need to be addressed. The infected patients often present clinical symptoms with fever, dyspnea, fatigue, diarrhea, vomiting, and dry cough, as well as pulmonary, infiltrates on imaging. Extensive measures to decrease person-to-person transmission of COVID-19 are being implemented to prevent, recognize, and control the current outbreak as it is very similar to SARS-CoV in its clinical spectrum, epidemiology, and pathogenicity. In response to this fatal disease and disruptive outbreak, it is extremely vital to expedite the drug development process to treat the disease and vaccines for the prevention of COVID-19 that would help us defeat this pandemic expeditiously. This paper sums up and unifies the study of virological aspects, disease transmission, clinically administered techniques, therapeutics options, managements, future directions, designing of vaccines, and news dissemination pertaining to COVID-19. © 2020 by the authors. Licensee MDPI, Basel, Switzerland.
Other Related Docs
11. Covid-19 Management in the Emergency Ward, Journal of Research in Medical Sciences (2021)
15. A Comprehensive Review of Therapeutic Options for Covid-19, Ethiopian Journal of Health Development (2022)
18. Corticosteroid Therapy for 2019 Novel Coronavirus: Lessons From Sars and Mers, Avicenna Journal of Clinical Microbiology and Infection (2021)
20. Cytokines and Micrornas in Sars-Cov-2: What Do We Know?, Molecular Therapy Nucleic Acids (2022)
21. Recent Findings of Coronavirus: The Pathogenesis and Treatment, Journal of Isfahan Medical School (2020)
23. Immune System Changes During Covid-19 Recovery Play Key Role in Determining Disease Severity, International Journal of Immunopathology and Pharmacology (2020)
26. The Molecular Basis of Covid-19 Pathogenesis, Conventional and Nanomedicine Therapy, International Journal of Molecular Sciences (2021)
27. Potential Treatments for Covid-19; a Narrative Literature Review, Archives of Academic Emergency Medicine (2020)
29. Emerging Technologies for the Treatment of Covid-19, Advances in Experimental Medicine and Biology (2021)
32. Epidemiological Study of Covid-19 in Iran and the World: A Review Study, Infectious Disorders - Drug Targets (2022)
35. A Narrative Review of Covid-19: The New Pandemic Disease, Iranian Journal of Medical Sciences (2020)
46. Clinical Display, Diagnostics and Genetic Implication of Novel Coronavirus (Covid-19) Epidemic, European Review for Medical and Pharmacological Sciences (2020)
49. Vaccine Design and Delivery Approaches for Covid-19, International Immunopharmacology (2021)